Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Plandai Biotechnology Inc PLPL

Plandai Biotechnology, Inc. is a biotech company, which is focused on the production of botanical extracts for the nutraceutical and pharmaceutical industries. The Company grows the green tea used in its products on a 3,000-hectare estate in the Mpumalanga region of South Africa. Its marketed product, Phytofare Catechin Complex, is a green-tea-derived extract that has multiple potential... see more

Recent & Breaking News (OTCPK:PLPL)

Plandai Biotechnology, Inc. Announces Rescission of Material Definitive Agreement with Good Salt, LLC

Accesswire August 1, 2023

Third-Party Valuation Firm Provides Estimated Valuation of ByoPlanet's (A Subsidiary Of Plandai - $PLPL) Business and Assets

Accesswire May 31, 2023

Byoplanet Unveils Bold Roadmap for the Upcoming Year, Under the Leadership of CEO Rick O'Shea

Accesswire May 31, 2023

ByoPlanet's bCOOL(TM) Cooling Technology Enhances Performance and Recovery for Major League and College Teams

Accesswire May 25, 2023

ByoPlanet and Merck Animal Health Announce Partnership with USEF

Accesswire May 23, 2023

Plandai Subsidiary ByoPlanet Announces Strategic Distribution Agreement with Merck Animal Health

Accesswire May 19, 2023

Following Completed Share Exchange Agreement with ByoPlanet, Plandai Announces Material Rebranding to Disinfectant Industry Focus

Accesswire May 18, 2023

ByoPlanet Announces Completion of Share Exchange Agreement with Plandai Biotechnology

Accesswire May 17, 2023

Plandai Biotechnology, Inc. Announces Entry into Material Share Exchange Agreement with Good Salt, LLC

Accesswire March 20, 2023

Plandai Biotechnologies, Inc. Announces Termination of Asset Acquisition Agreement with EV Hotel, Updates on Status of Independent Audit

Accesswire January 4, 2023

EV Hotel Corp. and Plandai Biotechnologies Enter Into Asset Acquisition Agreement to Create the Leading Smart Hotel Brand - EV Hotel Corp.

Accesswire November 8, 2022

Plandai Biotechnologies, Inc. Announces Entry into Non-Binding Letter of Intent, Updates on Status of Independent Audit

Accesswire October 6, 2022

Plandai Biotechnology, Inc. Announces Termination of Non-Binding Letter of Intent

Accesswire July 27, 2022

SEC Cancels Regulatory Penalty and Interest Concerning Legacy Civil Enforcement Action

Accesswire June 22, 2022

Plandai Biotechnology In Non-Binding Letter of Intent to Acquire Rights to Puriblood's Leukocyte Reduction Blood Filtration System with Plans to Address the International Blood Filtration Market

Accesswire May 23, 2022

Plandai Biotechnology Provides Comment on SEC Action

GlobeNewswire August 23, 2018

Plandaí Biotechnology Announces Successful Completion of Government Inspection of Affiliate Protext Pharma’s Proposed Medical Cannabis Facility

GlobeNewswire July 17, 2018

Plandai Biotechnology Exploring Opportunities in the U.S. Poultry Market

GlobeNewswire July 3, 2018

Plandaí Biotechnology to Focus on International Nutraceutical Cannabis Opportunities

GlobeNewswire June 19, 2018

Plandai Biotechnology Discusses Cannabis Extract Opportunities and Research Potential

GlobeNewswire June 14, 2018